Johns Hopkins University Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 489
• Ovarian cancer diagnosis and treatment 425
• Cervical Cancer and HPV Research 166
• Uterine Myomas and Treatments 80
• PARP inhibition in cancer therapy 49
• Gestational Trophoblastic Disease Studies 41
• Genetic factors in colorectal cancer 37
• Cancer survivorship and care 23
• Advanced Radiotherapy Techniques 22
• Advances in Oncology and Radiotherapy 22
• BRCA gene mutations in cancer 19
• Intraperitoneal and Appendiceal Malignancies 19

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Joseph Buscema

2. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Ritu Salani, Stefanie Ueda

3. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Stephanie Gaillard, Ritu Salani, Stefanie Ueda

4. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Joseph Buscema

5. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations ·